United States Food and Drug Administration (USFDA) has conducted a Pre-Approval Inspection (PAI) and Good Manufacturing Practice (GMP) inspection at Bliss GVS Pharma’s manufacturing unit at Dewan Udyog Nagar, Aliyali Village, Palghar, Maharashtra from March 13, 2023 to March 17, 2023. After the inspection, the USFDA issued a Form 483 with 3 minor observations.
The observations are procedural in nature. The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations.
Bliss GVS Pharma is a fast-growing Pharmaceutical Company with a proven track record of developing, manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: